Delivery Order SPE2DB24D1205-SPE2DB25FCTDJ

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,263.54, is a Delivery Order for the supply of 50 mg Losartan Potassium tablets. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,387.32 delivery order contract is for the supply of 1,000 units of Losartan Potassium 25 mg tablets, a cardiovascular medication. The contract has a firm fixed price and an ultimate completion date of February 27, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,415.25 for the delivery of 4,566,949,578 units of Losartan Potassium 50 mg tablets. The award has an ultimate completion date of January 16, 2025 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,487.94 firm fixed-price delivery order is for the supply of 1,000 units of Losartan Potassium 50 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,882.12 firm-fixed-price delivery order covers the supply of 4,566,816,335 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract award to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,537.34 firm fixed-price contract is for the delivery of 4,565,391,981 units of Losartan Potassium 50 mg tablets by August 9, 2024. This order is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,109.79 firm fixed-price contract is for the delivery of 1,000 tablets of Losartan Potassium 100 mg, a cardiovascular medication. The contract has an ultimate completion date of July 29, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,083 firm-fixed-price delivery order is for the supply of 4,564,015,207 units of Losartan Potassium 50 mg tablets. The contract has an ultimate completion date of March 20, 2024 and does not have any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,403.12, is for the delivery of 4566450300 - LOSARTAN-HCTZ 100-25 MG TAB 90S, a cardiovascular medication, with a completion date of November 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,677,679 units of Losartan Potassium 50 mg tablets. The $1,996.04 firm fixed price delivery order has an ultimate completion date of April 24, 2023 and was awarded on April 21, 2023. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTDJ
    Delivery Order

This contract award, valued at $1,366.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Losartan Potassium 50 mg tablets, a cardiovascular medication, to support military healthcare programs. The contract is a firm-fixed-price delivery order with a completion date of January 21, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 9:45 AM